Risk Control Safety Assessment ELSIE Consortium The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Mitigating Risks of Compounded Drugs Through Surveillance FDA What Is BPC 157? A Medical Clinic's Guide to the Body Protective Peptide, Its Uses, and What It Actually Does Perfect B Early evidence suggests BPC 157 repairs tissue rather than just dulling symptoms. To read more, tap the link in bio.